Renoprotective effect of combining angiotensin II receptor blockers and statins in diabetic rats.
Gao
Ping
P
Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, China. gp6680@sina.com
Jia
Ru-han
RH
Yang
Ding-ping
DP
Liu
Hong-yan
HY
Song
En-feng
EF
Chu
Gui-li
GL
Ding
Guo-hua
GH
D000818:Animals; D018932:Chemokine CCL2 / Q000032:analysis / Q000235:genetics; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy* / Q000503:physiopathology; D004359:Drug Therapy, Combination; D005229:Fatty Acids, Monounsaturated / Q000008:administration & dosage*; D000077340:Fluvastatin; D007211:Indoles / Q000008:administration & dosage*; D007668:Kidney / Q000187:drug effects* / Q000503:physiopathology; D008297:Male; D016328:NF-kappa B / Q000032:analysis; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D013777:Tetrazoles / Q000008:administration & dosage*; D051996:Transcription Factor RelA; D014633:Valine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D000068756:Valsartan
C491766:Ccl2 protein, rat; D018932:Chemokine CCL2; D005229:Fatty Acids, Monounsaturated; D007211:Indoles; D016328:NF-kappa B; D012333:RNA, Messenger; D013777:Tetrazoles; D051996:Transcription Factor RelA; D000077340:Fluvastatin; D000068756:Valsartan; D014633:Valine